Form Type: 4

SEC EDGAR Link
Accession Number:0001765581-19-000066
Date:2019-08-08
Issuer: JAZZ PHARMACEUTICALS PLC (JAZZ)
Original Submission Date:

Reporting Person:

MCSHARRY HEATHER ANN
5TH FL, WATERLOO EXCHANGE
WATERLOO RD DUBLIN 4, L2

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
ORDINARY SHARES 2019-08-08 A 1,920 a $0.00 9,424 direct
ORDINARY SHARES 2019-08-09 S 787 d $135.65 8,637 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
NON-QUALIFIED STOCK OPTION (RIGHT TO BUY) 137.12 2019-08-08 deemed execution date A 4,805 (a) 2029-08-07 ordinary shares 4,805 $137.12 4,805 direct
Footnotes
IDfootnote
f1 these restricted stock units are granted pursuant to the issuer's 2007 non-employee directors stock award plan. each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. subject to the reporting person's continuous service and certain additional conditions, these units will vest in full on august 1, 2020.
f2 shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
f3 reflects sales of ordinary shares executed in multiple transactions at prices ranging from $135.4549 to $135.65. the price reported reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the securities and exchange commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the sales were effected.
f4 these options are granted pursuant to the issuer's 2007 non-employee directors stock award plan. subject to the reporting person's continuous service and certain additional conditions, these options will vest in 12 equal monthly installments beginning on september 1, 2019.
WhaleWisdom Logo

Elevate your investments